Black Cumin (Nigella sativa) is a well known spice in the Middle East and India. Less familiar in the West, it is often confused with the more common cumin (Cuminum cyminum).  Black cumin grows well in the Mediterranean region and in Western Asian countries including India, Pakistan and Afghanistan. It has a long history and is described in many ancient texts, including the Bible.  Black cumin seeds were found in the tomb of the Egyptian Pharaoh Tutankhamen, and Hippocrates commented on its many benefits.  In our own time, the results of modern research have begun to support a famous statement attributed to the Prophet Mohammad, referring to it “a remedy for every disease except death.”

In Ayurveda, black cumin is also called kalonji, upakuncika, karavi, and krishnajiraka. It is known to balance both Vata and Kapha, and increase Pitta. Its tastes are pungent and bitter, and it energetic action is heating. In both India and the Middle East it is traditionally used to help conditions such as: congestion, bronchitis, asthma, gastrointestinal problems, fever, woman’s health problems, eczema, pain, headaches, and to strengthen Agni.

Black Cumin and it Effects

Over 500 studies have been conducted over the last two decades showing the extraordinary range of benefits conferred by black cumin and its components including: antioxidant (1-3), antimicrobial (4-8), anthelmintic (9), antischistosomiasis (10), renal protective (11-13), gastroprotective and antiulcer (14,15), anti-inflammatory, immunomodulatory, analgesic and antipyretic (16-24), hepatoprotective (25-28), antiasthmatic, bronchodilator, and calcium antagonist (29, 30), diuretic and antihypertensive (31, 32), antiatherosclerotic and antihyperlipidemic (33-35), and antihypoglycemic and antidiabetic (36-40) effects.

While most of these papers have been animal or laboratory studies, a number of human studies have also been conducted. For example, in the area of respiratory disease, an early clinical study was done at Humboldt University in Berlin, Germany, in 2003, studying the effects of black cumin on 152 patients with allergic diseases (allergic rhinitis, bronchial asthma, atopic eczema). Improvements in symptoms were found across the board, with a slight decrease in plasma triglycerides and a discrete increase in HDL cholesterol, while the lymphocyte subpopulations, endogenous cortisol levels, and ACTH release remained unchanged (41).

Another human clinical study conducted in Indonesia was published in 2007 and examined the symptomatic treatment of acute tonsillopharyngitis in patients, using a combination of extract of black cumin with another herb called Phyllanthus niruri. The researchers found a significant benefit compared to a placebo in the treatment of acute tonsillopharyngitis (42). A study done in Iran, and published in 2007, examined the possible prophylactic effect of black cumin seed extract in asthmatic patients. Previous animal studies had demonstrated the relaxant, anticholinergic, and antihistaminic effects of black cumin. In this study, 29 asthmatic adults were divided into two groups and studied for 3 months. All symptoms in the group taking black cumin were significantly improved as compared to those of the control group. Also, the use of inhaler and oral beta-agonists, oral corticosteroid, and oral theophylline, decreased at the end of the study in the group using black cumin, while there were no obvious changes in the control subjects (43)

A second study done in Iran in 2008 examined the prophylactic effect of a boiled aqueous extract of black cumin seed on chemical war victims. Forty chemical war victims were randomly divided into a control group (taking a placebo daily) and study group (taking black cumin extract daily), and studied for 2 months. All respiratory symptoms, chest wheezing, and pulmonary function test values in the study group significantly improved in the second and third examination, compared to the first examination.  Bythe third examination, all pulmonary functions test values, and most symptoms in the study group were significantly improved compared to those of the control group. In the control group, there were only small improvements in some parameters in the second and third visits. The use of inhaler and oral beta-agonists, and oral corticosteroids in the study group, decreased by the end of the study, while there were no obvious changes in use of these drugs in control subjects (44).

Finally, a third study by the same group in Iran was published in 2010. They examined the effect of two doses of boiled extract of black cumin upon the airways of 15 asthmatic patients. Results showed that the extract caused significant increases in all measured pulmonary function tests. The timing of the onset of the bronchodilatory effect of the extract was similar to that of theophylline, however the effects of both doses of the extract were significantly less than that of theophylline or salbutamol (45).

In the area of cardiovascular disease, a randomized, double-blind, placebo-controlled study in Iran was published in 2008 and investigated the use of black cumin in patients with mild hypertension. Subjects were randomized into three groups: a placebo group, and two test groups which received 100 and 200 mg of black cumin extract twice a day. After 8 weeks, systolic and diastolic blood pressure values in all three case groups were found to be significantly reduced when compared with the baseline values for each group, and statistically reduced compared to the placebo group. Black cumin extract also caused a significant decline in the level of total and low-density-lipoprotein (LDL)-cholesterol (46). In another study conducted in Pakistan a year later, 123 people were recruited for a randomized, double-blind controlled trial. This study examined serum lipid levels, blood sugar, blood pressure, and body weight, with the use of black cumin. Only 71 of the subjects completed the study and the results did not show significantly different changes from controls, even though there was an improvement in almost all variables. The authors recommend that a larger study be conducted with an adequate sample size (47).

In two other studies conducted in Pakistan, patients taking black cumin showed significant improvement in both cholesterol and lipid level (48,49). A clinical study done at Isfahan University of Medical Sciences, Isfahan, Iran, and published in 2012, examined the effects of black cumin on hypercholesterolemia in a randomized, placebo-controlled clinical trial involving some 88 subjects. The results showed a decrease in total cholesterol, low-density lipoprotein and triglycerides (50). Several articles have reviewed the various effects of black cumin on hypertension and cardiovascular disease, and commented that its cardiovascular protective effects may be due to its multiple actions as: an antioxidant, a cardiac depressant, a diuretic, and a calcium channel blocker (51, 52).

The anti-diabetic properties of black cumin have been studied extensively in animals but not in humans (40). However, there have been related studies. For example, a well controlled study conducted in Indonesia and published in 2010, studied the effects of black cumin on testosterone levels and metabolic disturbances in obese men. The results showed that in a comparison between the treatment group using black cumin and the control group using a placebo, there was a very significant reduction in body weight and waist circumference, but an insignificant reduction of serum free testosterone, and systolic and diastolic blood pressure (53). In another study published in 2008 and conducted in North India, 60 patients who met specific criteria for insulin resistance syndrome were divided into two groups. The control group took 10 mg of atorvastatin once a day and 500 mg of metformin (both in tablet form) twice a day, for a period of 6 weeks. The experimental group patients took 10 mg of atorvastatin once a day, and 500 mg of metformin (both in tablet form) twice a day, and 2.5 ml of black cumin oil twice daily, for a period of 6 weeks. The treatment group showed significant improvement with reference to total cholesterol, low-density lipoprotein cholesterol, and fasting blood glucose. Researchers concluded that black cumin was effective as an add-on therapy in patients with insulin resistance syndrome, and has significant activity in diabetic and dyslipidemic patients (54).

In a study done at King Saud University in Riyadh, Saudi Arabia, and published in 2010, the effects of black cumin was examined on the metabolic activities of the enzymes and genes CYP3A4 and CYP2D6, which are part of cytochrome P450 system and involved in liver detoxification. Black cumin significantly inhibited CYP2D6 and CYP3A4 mediated metabolism of dextromethorphan in human liver microsomes and in healthy human volunteers (55).

Early research showed the positive effects of black cumin in an animal model of rheumatoid arthritis (56). More recently, a study done in Egypt in 2012 was a placebo-controlled design, which investigated the effects of black cumin on 40 female patients with rheumatoid arthritis. A significant improvement in a number of clinical measures used to evaluate the symptoms of rheumatoid arthritis was found with the use of black cumin as compared to a placebo (57).

Recent research done in 2011 in Iran, examined the effects of thymoquinone extracted from black cumin on intractable pediatric seizures in a double-blinded crossover clinical trial study.  A significant reduction of frequency of seizures in comparison with the control group was found (58). Another study conducted in 2013, looked at the effects of black cumin on cognitive functions. Previous studies had shown the neuroprotective effects of black cumin on animals (59), and this study demonstrated its role in enhancing memory, attention and cognition in humans. The authors suggest that it could be considered as potential food supplement for preventing or slow progressing of Alzheimer disease (60). Finally, a study done in 2008 in Pakistan, investigated the effects of black cumin on 35 addicts and found that is effective in long-term treatment of opioid dependence, also curing the infections from which majority of addicts suffer (61).

Black Cumin and Cancer

Past research has identified a number of spices and herbs as potential anti-cancer agents including: turmeric (curcumin), red chilli (capsaicin), cloves (eugenol), ginger (zerumbone), fennel (anethole), kokum (gambogic acid), fenugreek (diosgenin), and black cumin (thymoquinone) (62). PudMed lists over 100 papers on the effects of black cumin and its principle active ingredient, thymoquinone, against a wide range of different cancers, including breast, pancreatic, colon, prostate, and even liver, lung, and brain cancers.

Among the first studies were those from the Amala Research Center in Trichur, India, which reported in 1989 the use of black seed oil as a potential anticancer agent (63-65). In the US, similar findings were obtained by the Cancer Research Facility at Hilton Head Island, South Carolina, and at the Natural Products Chemistry laboratory in Lexington, Kentucky (66). Other laboratories in Egypt and Singapore were also studying the effects of black cumin on cancer (67- 69). More and more studies continued to be published, and report the anti-cancer effects of black cumin on different types of cancer. For example, a study in 2003 at Jackson State University in Florida, found black cumin effective against breast cancer cells, and another study in 2005 in Ireland, showed its effectiveness against lung cancer, cancer of the larynx, colon cancer, and pancreatic cancer cell lines (70, 71). Researchers at the Henry Ford Hospital in Michigan looked more closely at the mechanism involved, and observed that thymoquinone was able to inhibit DNA synthesis, proliferation, and viability of cancerous cells, but not noncancerous prostate cells, by suppressing specific gene expression (72). Further studies on the effects of black cumin on prostate cancer indicate that at low dosage, thymoquinone inhibits tumor angiogenesis and human prostate tumor growth with almost no chemotoxic side effects (73).

In the US, a study in 2009 showed that thymoquinone increased the effectiveness of chemotherapeutic agents in the killing of pancreatic cells, again by affecting specific gene expression. In another study the same year, thymoquinone was shown to induced apoptosis (preprogrammed cell death) and inhibited proliferation in pancreatic cancer cells (74,75). In 2010, a paper was published on a study conducted in Tanta, Egypt, on the use of black cumin against colon cancer in rats, and it was found to greatly reduce the size of the colon tumors; it also reduced tumors in the lungs and alimentary canals (76). Another study in 2010, showed that black cumin could stop cancer cellular proliferation in multiple organ sites, including colon, lung, and esophageal tumors, with no evidence of clinical side effects (77).

Studies in Egypt have shown that bee honey mixed with black cumin induces apoptosis in liver cancer cells and improves their antioxidant status (78). A 2010 study conducted at the Alexandria University in Egypt, found marked improvements when conventional chemotherapy was combined with herbal therapy (using black cumin among other herbs) on the incidence of side effects of chemotherapy in 2nd stage breast cancer patients (79). A more recent study published in 2013, revealed that black cumin induces apoptosis in cervical cancer cells through activation of specific enzymes (80).

Biological Mechanism

Many active pharmacologically important ingredients have been found in black cumin, including thymoquinone, dithymoquinone, thymohydroquinone, and thymol. Thymoquinone is the most well studied component, and is considered to be the active ingredient with many different effects. It is a relatively safe compound, particularly when given orally (81-83).

Thymoquinone acts as an anticancer and anti-inflammatory agent in a number of different ways. An excellent review by Khan and coworkers suggests that it induces apoptotic cell death in cancerous tissues by upregulating the expression of apoptotic genes (caspases and bax), and down-regulating the expression of anti-apoptotic genes (e.g.,bcl 2); it suppresses Akt activation by dephosphorylation and thus blocks cancer cell survival; it deactivates the important NFkappa B pathway, which is key to promoting inflammation and cancer; and it increases the activities of antioxidant enzymes and protects cell against cancer. In addition, it protects against normal cell injury that can be caused by the ionizing radiation used in some cancer treatments. It also has a hepatoprotective role, which is helpful in cancer prevention and treatment (84). These same anti-cancer mechanisms of thymoquinone have also been reviewed in several other papers (85-87). One of these papers reviewed the effects of thymoquinone combined with conventional chemotherapeutic drugs and found that the combination could produce greater therapeutic effect, as well as reduce the toxicity of the drugs (87).

In another study in India published in 2013, investigators found that thymoquinone targets cellular copper in prostate cancer cell lines, leading to a prooxidant cell death. They believe that such a prooxidant cytotoxic mechanism better explains the anticancer activity of plant-derived antioxidants (88). Researchers at Tulane University School of Medicine in New Orleans published a study in 2010 on the molecular mechanisms involved in thymoquinone induced cell death, showing that it is primarily due to increased reactive oxygen species generation and decreased glutathione levels, and is independent of androgen receptor activity (89). Another study conducted and published by the Anderson Cancer Center in Houston in 2010, demonstrated that encapsulation of thymoquinone into nanoparticles enhances its anti-proliferative, anti-inflammatory, and chemosensitizing effects (90).

Finally, a recent paper published in 2013 from research conducted at the University of Toyama in Japan, examined the effect of black cumin on inducible nitric oxide synthase enzyme activity, which has been implicated in the growth of various tumors. It was found that black cumin attenuated the inducible nitric oxide synthase pathway and suppressed the inflammatory response mediated by tumor necrosis factor-α and interleukin-6, again suggesting black cumin’s role as a natural and effective anticancer and anti-inflammatory agent (91).

1. Badary, O.A., Taha, R.A., Gamal el-Din, A.M. and Abdel-Wahab, M.H. (2003). Thymoquinone is a potent superoxide anion scavenger. Drug Chem. Toxicol. 26: 87-98.
2. Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol. 2005 May-Jun;25 (3):218-23.
3. Sen, N, Kar Y, Tekeli,Y. Antioxidant Activities of Black Cumin (Nigella Sativa L.) Seeds Cultivating In Different Regions of Turkey. J Food Biochemistry: Volume 34, Issue Supplements, pages 105–119, March 2010;
4. Topozada HH, Masloum H, El-Dakhakhany M. The antibacterial properties of Nigella sativa seeds: Active principle with some clinical application. J Egypt Med Assoc,1965;48(suppl):187–202.
5. Khan MA, Ashfaq MK, Zuberi HS, Mahmood MS, Gilani AH. The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds. Phytother Res. 2003; 17: 183–6.
6. Aljabre SHM, Randhawa MA, Akhtar A, Alakloby OM, Alqurashi AM and Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. Journal of Ethnopharmacology, 2005;101(1–3):116–9.
7. Sokmen A, Jones BM, Erturk M. The in vitro antibacterial activity of Turkish medicinal plants. J Ethnopharmacol. 1999; 67:79–86.
8. Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotic resistant bacteria. Acta Microbiol Pol, 2000; 49(1):63–74.
9. Akhtar MS, Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pakistan Med Assoc. 1991; 41:185–7.
10. EI Shenawy, N.S., Soliman, M.F. and Reyad, S.I. (2008). The effect of antioxidant properties of aqueous garlic extract and Nigella sativa as anti-schistosomiasis agents in mice. Rev. Inst. Med. Trop. Sao. Paulo., 50: 29-36.
11. Bayrak, O., Bavbek, N., Karatas, O.F., Bayrak, R., Catal, F., Cimentepe, E., Akbas, A., Yildirim, E., Unal, D. and Akcay, A. (2008). Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol. Dial. Transplant. 23: 2206-2212
12. Uz, E., Bayrak, O., Uz, E., Kaya, A., Bayrak, R., Uz, B., Turgut, F.H., Bavbek, N., Kanbay, M. and Akcay, A. (2008). Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: an experimental model. Am. J. Nephrol., 28: 517-522
13. Ragheb, A., Attia, A., Eldin, W.S., Elbarbry, F., Gazarin, S. and Shoker, A. (2009). The protective effect of thymoquinone, an antioxidant and anti-inflammatory agent, against renal injury: a review. Saudi J. Kidney Dis. Transpl., 20: 741-752.
14. Al Mofleh IA, Al Haider AA, Mossa JS, Al-Sohaibani MO, Al-Yahya MA, Rafatullah S, et al. Gastroprotective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi J Gastroenterol. 2008;14(3):128–34.
15. Salem EM et al. Comparative Study of Nigella sativa and Triple Therapy in Eradication of Helicobacter pylori in Patients with Non-Ulcer Dyspepsia. Saudi J Gastroenterol. 2010 July; 16(3): 207–214.
16. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy. 1993;70:237–42.
17. Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol. 2001;76:45–48.
18. Mutabagani A, El-Mahdy , Samiha HM. A study of anti-inflammatory activity of Nigella sativa L and thymoquinone in rats. Saudi Pharm J. 1997;5:110–3.
19. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res 2004;18(3):195-199.
20. El Gazzar MA, El Mezayen R, Nicolls MR, Dreskin SC.Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation. Biochim Biophys Acta.2007 Apr; 1770(4):556-64
21. Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 2009 Aug; 11(5):373-81.
22. Houghton PJ, Zarka R, Heras B, Hoult RS. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leucocytes and membrane lipid peroxidation. Planta Med. 1995.
23. Marsik P, Kokoska L, Landa P, Nepovim A, Soudek P, Vanek T. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med. 2005 Aug; 71(8):739-42.
24. Abdel-Fattah AM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol. 2000;400:89–97.
25. Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Let. 1998;95:23–9.
26. Kanter M, Coskun O, Budancamanak M. Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol 2005;11(42):6684-6688
27. Pari, L. and Sankaranarayanan, C. (2009). Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci., 85: 830-834.
28. Ojha S, Al-Suhaimi EA. Hepatoprotective and Immunological Functions of Nigella sativa Seed Oil against Hypervitaminosis A in Adult Male Rats. Int J Vitam Nutr Res. 2012 Aug;82(4):288-97.
29. Badar El-Din MK. Antiasthmatic activity of the active principle of Nigella sativa “Nigellone”. Gazette Egypt Paediatr Assoc,1960;8(4):864–7.
30. Gilani AH, Aziz N, Khurram IM, Chaudhary KS, Iqbal A. Bronchodilator, spasmolytic and calcium anatagonist activities of Nigella sativa seeds (Kalonji): A traditional herbal product with multiple medicinal uses. J Pak Med Assoc. 2001;51:115–20.
31. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie. 2000;55:379–82.
32. Khattab, M.M. and Nagi, M.N. (2007). Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother. Res., 21: 410-414.
33. Dahri, A.H., Chandiol, A.M., Rahoo, A.A. and Memon, R.A. (2005). Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. J. Ayub. Med. Coll. Abbottabad., 17: 72-74.Nader et al., 2010).
34. Nader, M.A., el-Agamy, D.S. and Suddek, G.M. (2010). Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch. Pharm. Res., 33: 637-643.
35. Kocyigit, Y., Y. Atamer and E. Uysal, 2009. The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats. Saudi Med. J., 30: 893-896. Saudi Med J. 2009 Jul;30(7):893-6.
36. Al-Hader A, Aqel A, Hassan Z. Hypogycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacol. 1993;31:96–100.
37. Kanter, M., Akpolat, M. and Aktas, C. (2009). Protective effects of the volatile oil of Nigella sativa seeds on beta-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study. J. Mol. Histol., 40: 379-385
38. Benhaddou-Andaloussi A, Martineau LC, Vallerand D, Haddad Y, Afshar A, Settaf A Haddad PS. Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes Metab. 2010 Feb;12(2):148-57.
39. Eskander EF, Jun HW, Ibrahim KA, Abdelal WE. Hypoglycemic effect of a herbal formulation in alloxan induced diabetic rats Egypt J Pharm Sci, 1995;36(1–6):253–70.
40. Mathur ML, Gaur J, Sharma R, Haldiya KR. Antidiabetic Properties of a Spice Plant Nigella sativa. J Endocrinol Metab 2011;1(1):1-8.)
41. Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ, Kiesewetter H. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res. 2003 Dec;17(10):1209-14
42. Dirjomuljono M, Kristyono I, Tjandrawinata RR, Nofiarny D. Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int J Clin Pharmacol Ther. 2008 Jun;46(6):295-306.
43. Boskabady MH, Javan H, Sajady M, Rakhshandeh H. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam Clin Pharmacol. 2007 Oct;21(5):559-66
44. Boskabady MH, Farhadi J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med 2008;14(9):1137-1144.
45. Boskabady, M.H., Mohsenpoor, N. and Takaloo, L. (2010). Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine. 2010 Aug;17(10):707-13
46. Dehkordi, F.R. and Kamkhah, A.F. (2008). Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam. Clin. Pharmacol., 22: 447-452.
47. Qidwai,W., H.B. Hamza and A. Gilani, 2009. Effectiveness, safety and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum Lipid levels, blood sugar, blood pressure and body Weight in adults: Results of a randomized, double-blind controlled trial. J. Altern Complement Med., 15: 639-644.
48. Tasawar Z, Siraj Z, Ahmad N, and Lashari MH, The Effects of Nigella sativa(Kalonji) on Lipid Profile in Patients with Stable Coronary Artery Disease in Multan, Pakistan. Pakistan Journal of Nutrition 10 (2): 162-167, 2011
49. Bhatii IU, Rehman FU, Khan MA and Marwat SK, Effect of Prophetic Medicine Kalonji (Nigella sativa L.) On lipid Profile of Human Beings: an In Vivo Approach. World Applied Sciences Journal 6 (8): 1053-1057, 2009
50. Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, Asgary S, Ghannadi A.Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arh. 2012;66(3):198-200.
51. Leong XF, Mustafa, MF, and Jaarin K. Review Article Nigella sativa and Its Protective Role in Oxidative Stress and Hypertension. Evidence-Based Complementary and Alternative Medicine. Volume 2013 (2013),
52. Shabana A, El-Menyar A, Asim M, Al-Azzeh H, Al Thani H, Cardiovascular Benefits of Black Cumin (Nigella sativa). Cardiovascular Toxicology. Mar 2013, Vol. 13, No. 1: 9-21
53. Datau EA, Wardhana, Surachmanto EE, Pandelaki K, Langi JA, Fias. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 2010;42(3):130-134.).
54. Najmi A, Nasiruddin M, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev Ctries 2008;28(1):11-14.)
55. Al-Jenoobi FI, Al-Thukair AA, Abbas FA, Ansari MJ, Alkharfy KM, Al-Mohizea AM, Al-Suwayeh SA, Jamil S. Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. Drug Metab Lett. 2010 Jan;4(1):51-5.
56. Tekeoglu I, Dogan A, Ediz L, Budancamanak M, Demirel A. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res 2007;21(9):895-897.)
57. Gheita TA, Kenawy SA. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytother Res. 2012 Aug;26(8):1246-8.
58. Akhondian J, Kianifar H, Raoofziaee M, Moayedpour A, Toosi MB, Khajedaluee M. The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res. 2011 Jan;93(1):39-43. 26.
59. Hosseinzadeh H, Parvardeh S, Asl MN, Sadeghnia HR, Ziaee T. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine. 2007 Sep; 14(9):621-7.
60. Bin Sayeed MS, Morshed, AH, Hossain M, Kadir, MF, Rahman R, The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers. Journal of Ethnopharmacology. May 2013
61. Sangi S, Ahmed SP, Channa MA, Ashfaq M, Mastoi SM.A new and novel treatment of opioid dependence: Nigella sativa 500 mg. J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):118-24.
62. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P Potential of Spice-Derived Phytochemicals for Cancer Prevention Planta Med. 2008;74:1560–1569
63. Salomi MJ, Panikkar KR, Kesavan M, Donata K Sr, Rajagopalan K. Anti-cancer activity of nigella sativa. Anc Sci Life. 1989 Jan;8(3-4):262-6.
64. Salomi MJ, Nair SC, Panikkar KR. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer. 1991;16(1):67-72
65. Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR. Antitumour principles from Nigella sativa seeds.
66. Worthen DR, Ghosheh OA, Crooks PA.The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res. 1998 May-Jun;18(3A):1527-32.
67. Badary OA, Al-Shabanah OA, Nagi MN, Al-Rikabi AC, Elmazar MM. Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur J Cancer Prev. 1999 Oct;8(5):435-40
68. Badary OA, Gamal El-Din AM. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev. 2001;25(4):362-8.
69. Swamy SM, Tan BK. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J Ethnopharmacol. 2000 Apr;70(1):1-7.
70. Farah IO, Begum RA.Effect of Nigella sativa (N. sativa L.) and oxidative stress on the survival pattern of MCF-7 breast cancer cells. Biomed Sci Instrum. 2003;39:359-64.
71. Rooney S, Ryan MF. Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines.  Anticancer Res. 2005 May-Jun;25(3B):2199-204.
72. Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, Menon M, Dou QP, Reddy GP. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res. 2007 Aug 15;67(16):7782-8.
73. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther. 2008 Jul;7(7):1789-96.
74. Banerjee S, et al. Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer.  Cancer Res. 2009 Jun 23.
75. Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 2009 Aug;11(5):373-81.
76. Wang CZ, Calway TD, Wen XD, Smith J, Yu C, Wang Y, Mehendale SR, Yuan CS. Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway. Int J Oncol. 2013 Mar; 42(3):1018-26.
77. Salim EI Cancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassay. Oncol Lett. 2010 September; 1(5): 913–924.
78. Hassan MI, Mabrouk GM, Shehata HH, Aboelhussein MM. Antineoplastic effects of bee honey and Nigella sativa on hepatocellular carcinoma cells. Integr Cancer Ther. 2012 Dec;11(4):354-63.
79. Khalil NHK, El- Din SA, Salem, MD. The Effect of Combining Herbal Therapy with Conventional Chemotherapy on the Incidence of Chemotherapy Side Effects in 2nd Stage Breast Cancer Patients. Journal of American Science 2010;6(11):784-801].
80. Hasan TN, Shafi G, Syed NA, Alfawaz MA, Alsaif MA, Munshi A, Lei KY, Alshatwi AA. Methanolic extract of Nigella sativa seed inhibits SiHa human cervical cancer cell proliferation through apoptosis. Nat Prod Commun. 2013 Feb;8(2):213-6.
81. Bourgou, S., Ksouri, R., Bellila, A., Skandrani, I., Falleh, H. and Marzouk, B. (2008). Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C. R. Biol., 331: 48-55.
82. Khader, M., Bresgen, N. and Eckl, P.M. (2010). Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants.J. Ethnopharmacol., 127: 319-324.
83. Al-Ali, A., Alkhawajah, A.A., Randhawa, M.A. and Shaikh, N.A. (2008). Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub. Med. Coll. Abbottabad., 20: 252-257.
84. Khan MD, Chen HC, Tania M, Zhang DZ. Afr J Tradit Complement Altern Med. (2011) 8(S):226-232.
85. Padhye S,  Banerjee S, Ahmad A, Mohammad R, and  Sarkar FH. From here to eternity – the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther. 2008; 6(b): 495–510.
86. Randhawa MA, Alghamdi MS. Anticancer activity of Nigella sativa (black seed) – a review. Am J Chin Med. 2011;39(6):1075-91.
87. Woo CC, Kumar AP, Sethi G, Tan KH. Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol. 2012 Feb 15;83(4):443-51.
88. Zubair H, Khan HY, Sohail A, Azim S, Ullah MF, Ahmad A, Sarkar FH, Hadi SM. Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death Dis. 2013 Jun 6;4:e660.
89. Koka PS, Mondal D, Schultz M, Abdel-Mageed AB, Agrawal KC. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species. Exp Biol Med (Maywood). 2010 Jun;235(6):751-60
90. Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR, Aggarwal BB. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochem Pharmacol. 2010 Jun 1;79(11):1640-7.
91. Fathy M, Nikaido T. In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa. Environ Health Prev Med. 2013 Apr 23.
    [Epub ahead of print]

Copyright: Dr. Robert Keith Wallace